作者
Diogo Mota,Joana Miranda,Leonor Carneiro‐Leão,Josefina Cernadas
摘要
Iodinated contrast media (ICM) are widely used to enhance medical imaging. Fixed drug eruption (FDE) is a non-immediate hypersensitivity reaction that characteristically recurs in the same locations upon re-exposure to the offending drug. Although FDE due to ICM has been recognised, only a few cases have been reported over the years, often presenting with atypical manifestations as unusual localisation, disseminated lesions or generalised FDE.1 A 64-year-old male was referred to our Allergy and Clinical Immunology (ACI) department with a suspected hypersensitivity reaction to ICM. He reported patchy erythematous lesions affecting predominantly the anterior third of the left medial foot plus milder erythema on the medial surface of the calcaneus. Lesions had appeared a few hours after receiving ICM for urological examination 15 years earlier. ICM used was either iopromide or ioxithalamate, the exact information was impossible to obtain. Some years later, he mentioned the appearance of erythematous lesions at the exact some locations, 12 h after performing a coronary angiography with iopromide. Skin lesions improved progressively over 2 weeks, with associated desquamation (Figure 1A). Three months later, he underwent an angioplasty with iopromide and 6 h after receiving ICM, lesions reappeared in the previously targeted locations. The remaining physical exam was unremarkable. He was evaluated in our clinic and treated with oral antihistamine and topical corticosteroid, with resolution over 10 days without residual erythema or hyperpigmentation. A non-pigmented FDE associated with ICM was suspected. Two months after the last reaction, patch tests with undiluted iohexol, ioversol, iopromide and iomeprol on Finn Chamber® were applied at the medial anterior aspect of the left foot and at unaffected skin (on his back), removed and read after 48 h and then at 72 h. A positive result was obtained, consisting of erythema at previously affected sites, which fully reproduced the index reaction (Figure 1B). However, it was impossible to determine which of the ICM tested was responsible for the reaction. One month later patch tests with ICM were repeated. To ensure a more accurate identification of potential safe alternatives, we decided to apply iomeprol and ioversol at the more severely affected area. Iohexol was tested at the calcaneus (Figure 1C). All tests were negative. We then performed a drug provocation with ioversol, an alternative ICM, which was tolerated. In our case, the exact previous lesion was elicited by patch tests, which was unexpected, since these tests usually present with local erythema only at the site where the test is applied. The size of the elicited reaction hindered the identification of which of the tested ICM was responsible. Considering the small space available of affected skin and the fact that the patient had at least two reproducible episodes with iopromide, tests were repeated using only possible alternatives. According to the previously described cross-reactivity patterns in non-immediate reactions,2, 3 we applied most likely safe alternatives in most obviously affected areas. Then, we decided to perform a drug challenge with ioversol, the ICM with lower cross-reactivity with iopromide available at our hospital. FDE is an uncommon type of delayed-hypersensitivity reaction, especially to ICM, and so of major relevance to be reported. Prick tests have a limited role in diagnosis and intradermal tests have been seldomly used, currently having an unknown value in the diagnostic workup of FDE. Patch tests within the affected areas are the most useful diagnostic tool in these patients. Diogo Mota: Conceptualization; writing – review and editing; writing – original draft. Joana Miranda: Conceptualization; writing – original draft; writing – review and editing. Leonor Carneiro-Leão: Conceptualization; writing – original draft; writing – review and editing; supervision. Josefina Cernadas: Conceptualization; writing – original draft; writing – review and editing; supervision. This work received no funding. All authors disclose no financial and personal relationships with other people or organisations that could inappropriately influence their work. Informed consent was obtained from the patients to publish the case report along with all accompanying visual elements.